from
ISI Research Reports19 page (6122 word) report
published Jan 29, 2008
Price
$675.00 available for immediate download
Report Overview
Search Inside
About
ISI Research Reports
The Indonesian pharmaceutical sector experienced a growth in value, from USD1.6 billion at the end of 2006 to USD1.7 billion as at August 2007. Domestic manufacturing continues to develop and the possibilities of mergers between leading state-owned companies should boost the industry further. In 2006, Indonesian pharmaceutical companies controlled 65% of prescription sales and 75% of over-the-counter medicines relative to their foreign counterparts. Also, due to the decrease in generic drugs prices in 2006, it is anticipated that the generic drugs market will grow at an accelerated pace.
|
| Source: | ISI Analytics
|
| Document ID: | IP1
|
| Country: | Indonesia
|
| Industry: | Pharmaceutical
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Insight and analysis from ISI own on-the-ground analysts in the emerging markets, who combine original research with data from our proprietary industry databases.
